• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用扩增的路易体痴呆原纤维和放射自显影技术来表征放射性配体Tg-1-90B与死后脑组织中α-突触核蛋白原纤维的结合。

Use of Amplified Lewy Body Dementia Fibrils and Autoradiography to Characterize Binding of Radioligand Tg-1-90B to Alpha-Synuclein Fibrils in Postmortem Brain Tissue.

作者信息

O'Shea Jennifer Y, Dhavale Dhruva D, Hwang Helen, Smith Zachary, Graham Thomas J A, Mach Robert H, Kotzbauer Paul T

机构信息

Department of Neurology, Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, MO 63110, USA.

Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.

出版信息

Cells. 2025 Sep 22;14(18):1477. doi: 10.3390/cells14181477.

DOI:10.3390/cells14181477
PMID:41002442
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12468313/
Abstract

Parkinson's disease (PD) and Lewy Body Dementia (LBD) are defined by accumulation of alpha-synuclein (Asyn) fibrils within Lewy bodies (LBs) and Lewy neurites (LNs). The development of a Positron Emission Tomography (PET) tracer for quantifying Asyn fibrils would improve diagnostic accuracy and provide a biomarker for disease progression. We previously described radioligand [H]Tg-1-90B, which binds to in vitro Asyn fibrils (PDB 2N0A) via interactions with residues Y39, S42 and K44. Here, we performed molecular docking studies with Tg1-90B and PD/LBD Asyn fibrils (PDB 8A9L), which predicts interactions with residues Y39 and K43 in a structurally distinct binding site. In radioligand binding assays, Tg-1-90B has moderate to high affinity (K 17.5 nM) for amplified LBD fibrils (PDB 8FPT), whose protofilament fold is highly similar to PD/LBD fibrils (PBD 8A9L). Autoradiography confirmed binding of [H]Tg-1-90B to LBs in PD brain tissue. However, Tg-1-90B also binds to amyloid-beta fibrils in Alzheimer's disease (AD) tissue, indicating insufficient selectivity for Asyn fibrils. These results indicate that Tg-1-90B binds to Asyn fibrils in PD tissue but needs further structural optimization. Binding assays with amplified LBD fibrils and autoradiography with postmortem PD tissue can guide further development of Asyn fibril PET ligands for PD/LBD.

摘要

帕金森病(PD)和路易体痴呆(LBD)是由路易小体(LBs)和路易神经突(LNs)内α-突触核蛋白(Asyn)纤维的积累所定义的。开发一种用于定量Asyn纤维的正电子发射断层扫描(PET)示踪剂将提高诊断准确性,并为疾病进展提供生物标志物。我们之前描述了放射性配体[H]Tg-1-90B,它通过与Y39、S42和K44残基的相互作用与体外Asyn纤维(PDB 2N0A)结合。在这里,我们用Tg1-90B和PD/LBD Asyn纤维(PDB 8A9L)进行了分子对接研究,该研究预测了在结构上不同的结合位点与Y39和K43残基的相互作用。在放射性配体结合试验中,Tg-1-90B对扩增的LBD纤维(PDB 8FPT)具有中度至高亲和力(K 17.5 nM),其原纤维折叠与PD/LBD纤维(PBD 8A9L)高度相似。放射自显影证实了[H]Tg-1-90B与PD脑组织中LBs的结合。然而,Tg-1-90B也与阿尔茨海默病(AD)组织中的淀粉样β纤维结合,表明对Asyn纤维的选择性不足。这些结果表明,Tg-1-90B与PD组织中的Asyn纤维结合,但需要进一步的结构优化。用扩增的LBD纤维进行结合试验和用死后PD组织进行放射自显影可以指导用于PD/LBD的Asyn纤维PET配体的进一步开发。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9801/12468313/e9a2f680e9b5/cells-14-01477-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9801/12468313/269ad648104f/cells-14-01477-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9801/12468313/750cd2451d4f/cells-14-01477-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9801/12468313/c80831c601e6/cells-14-01477-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9801/12468313/03e5743d8452/cells-14-01477-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9801/12468313/e9a2f680e9b5/cells-14-01477-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9801/12468313/269ad648104f/cells-14-01477-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9801/12468313/750cd2451d4f/cells-14-01477-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9801/12468313/c80831c601e6/cells-14-01477-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9801/12468313/03e5743d8452/cells-14-01477-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9801/12468313/e9a2f680e9b5/cells-14-01477-g005.jpg

相似文献

1
Use of Amplified Lewy Body Dementia Fibrils and Autoradiography to Characterize Binding of Radioligand Tg-1-90B to Alpha-Synuclein Fibrils in Postmortem Brain Tissue.使用扩增的路易体痴呆原纤维和放射自显影技术来表征放射性配体Tg-1-90B与死后脑组织中α-突触核蛋白原纤维的结合。
Cells. 2025 Sep 22;14(18):1477. doi: 10.3390/cells14181477.
2
Structure of alpha-synuclein fibrils derived from human Lewy body dementia tissue.来源于人类路易体痴呆组织的α-突触核蛋白纤维的结构。
Nat Commun. 2024 Mar 29;15(1):2750. doi: 10.1038/s41467-024-46832-5.
3
Identification of a Putative α-synuclein Radioligand Using an in silico Similarity Search.利用计算机模拟相似性搜索鉴定潜在的α-突触核蛋白放射性配体。
Mol Imaging Biol. 2023 Aug;25(4):704-719. doi: 10.1007/s11307-023-01814-9. Epub 2023 Mar 29.
4
Alpha-synuclein seeding amplification assays in Lewy body dementia: a brief review.路易体痴呆中的α-突触核蛋白种子扩增检测:简要综述
Mol Neurodegener. 2025 Jul 1;20(1):77. doi: 10.1186/s13024-025-00868-3.
5
Development of Pyridothiophene Compounds for PET Imaging of α-Synuclein.用于α-突触核蛋白PET成像的吡啶并噻吩化合物的研发
Chemistry. 2024 Apr 22;30(23):e202303921. doi: 10.1002/chem.202303921. Epub 2024 Mar 8.
6
Quantifying regional α -synuclein, amyloid β, and tau accumulation in lewy body dementia.定量检测路易体痴呆症中 α -突触核蛋白、淀粉样β 和 tau 的区域性积累。
Ann Clin Transl Neurol. 2022 Feb;9(2):106-121. doi: 10.1002/acn3.51482. Epub 2022 Jan 21.
7
Posterior hippocampal sparing in Lewy body disorders with Alzheimer's copathology: An in vivo MRI study.路易体疾病合并阿尔茨海默病共同病理改变时海马后部的保留:一项活体MRI研究
Neuroimage Clin. 2025;45:103714. doi: 10.1016/j.nicl.2024.103714. Epub 2024 Dec 7.
8
Tissue Factor and Its Cerebrospinal Fluid Protein Profiles in Parkinson's Disease.组织因子及其在帕金森病中的脑脊液蛋白谱。
J Parkinsons Dis. 2024;14(7):1405-1416. doi: 10.3233/JPD-240115.
9
Abundant non-inclusion α-synuclein pathology in Lewy body-negative LRRK2-mutant cases.路易体阴性的LRRK2突变病例中存在大量非包涵体型α-突触核蛋白病理改变。
Acta Neuropathol. 2025 May 2;149(1):41. doi: 10.1007/s00401-025-02871-w.
10
Discovery of -(6-Methoxypyridin-3-yl)quinoline-2-amine Derivatives for Imaging Aggregated α-Synuclein in Parkinson's Disease with Positron Emission Tomography.用于正电子发射断层扫描成像帕金森病中聚集的α-突触核蛋白的-(6-甲氧基吡啶-3-基)喹啉-2-胺衍生物的发现
Cells. 2025 Jul 18;14(14):1108. doi: 10.3390/cells14141108.

本文引用的文献

1
The development of a PET radiotracer for imaging alpha synuclein aggregates in Parkinson's disease.用于帕金森病中α-突触核蛋白聚集体成像的正电子发射断层显像(PET)放射性示踪剂的研发。
RSC Med Chem. 2025 Apr 3. doi: 10.1039/d5md00057b.
2
Positron emission tomography tracers for synucleinopathies.用于突触核蛋白病的正电子发射断层扫描示踪剂。
Mol Neurodegener. 2025 Jan 5;20(1):1. doi: 10.1186/s13024-024-00787-9.
3
Structure of alpha-synuclein fibrils derived from human Lewy body dementia tissue.来源于人类路易体痴呆组织的α-突触核蛋白纤维的结构。
Nat Commun. 2024 Mar 29;15(1):2750. doi: 10.1038/s41467-024-46832-5.
4
The α-synuclein PET tracer [18F] ACI-12589 distinguishes multiple system atrophy from other neurodegenerative diseases.α-突触核蛋白 PET 示踪剂[18F]ACI-12589 可将多系统萎缩与其他神经退行性疾病区分开来。
Nat Commun. 2023 Oct 27;14(1):6750. doi: 10.1038/s41467-023-42305-3.
5
Toward imaging of alpha-synuclein with PET.实现 PET 对 α-突触核蛋白成像。
Cell. 2023 Aug 3;186(16):3327-3329. doi: 10.1016/j.cell.2023.06.018.
6
Development of an α-synuclein positron emission tomography tracer for imaging synucleinopathies.用于成像突触核蛋白病的α-突触核蛋白正电子发射断层扫描示踪剂的开发。
Cell. 2023 Aug 3;186(16):3350-3367.e19. doi: 10.1016/j.cell.2023.06.004. Epub 2023 Jul 7.
7
Structures of α-synuclein filaments from human brains with Lewy pathology.具有路易体病理的人脑α-突触核蛋白纤维的结构。
Nature. 2022 Oct;610(7933):791-795. doi: 10.1038/s41586-022-05319-3. Epub 2022 Sep 15.
8
Opportunities and challenges of alpha-synuclein as a potential biomarker for Parkinson's disease and other synucleinopathies.α-突触核蛋白作为帕金森病和其他突触核蛋白病潜在生物标志物的机遇与挑战。
NPJ Parkinsons Dis. 2022 Jul 22;8(1):93. doi: 10.1038/s41531-022-00357-0.
9
Quantifying regional α -synuclein, amyloid β, and tau accumulation in lewy body dementia.定量检测路易体痴呆症中 α -突触核蛋白、淀粉样β 和 tau 的区域性积累。
Ann Clin Transl Neurol. 2022 Feb;9(2):106-121. doi: 10.1002/acn3.51482. Epub 2022 Jan 21.
10
Alpha-Synuclein PET Tracer Development-An Overview about Current Efforts.α-突触核蛋白正电子发射断层显像示踪剂的研发——当前研究进展概述
Pharmaceuticals (Basel). 2021 Aug 26;14(9):847. doi: 10.3390/ph14090847.